开云app官网登录入口网页版-官方正版

#球蛋白#

170篇内容 | 2836人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2035278, encodeId=308e20352e8aa, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=X连锁无丙种球蛋白血症：症状与体征、病因、流行病学、诊断与治疗, objectType=article, longId=737136, objectId=ce77e3713682, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce77e3713682, replyNumber=0, likeNumber=88, createdTime=2022-12-23, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce77e3713682, moduleTitle=X连锁无丙种球蛋白血症：症状与体征、病因、流行病学、诊断与治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ce77e3713682)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035277, encodeId=5b8c20352e792, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病, objectType=article, longId=730815, objectId=f09be30815b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f09be30815b3, replyNumber=0, likeNumber=108, createdTime=2022-11-08, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f09be30815b3, moduleTitle=新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f09be30815b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035276, encodeId=734220352e6a5, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=JAMA Netw open：川崎病患者对静脉注射免疫球蛋白无反应和冠状动脉异常的发生是否与年龄和性别有关?, objectType=article, longId=729623, objectId=8251e2962349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8251e2962349, replyNumber=0, likeNumber=106, createdTime=2022-07-16, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8251e2962349, moduleTitle=JAMA Netw open：川崎病患者对静脉注射免疫球蛋白无反应和冠状动脉异常的发生是否与年龄和性别有关?, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8251e2962349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035273, encodeId=dbb220352e36c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Front Immunol：20%皮下免疫球蛋白治疗自身免疫性肌炎和CVID患者的替代和免疫调节活性的回顾性研究, objectType=article, longId=295743, objectId=4627295e4350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4627295e4350, replyNumber=0, likeNumber=100, createdTime=2022-06-08, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4627295e4350, moduleTitle=Front Immunol：20%皮下免疫球蛋白治疗自身免疫性肌炎和CVID患者的替代和免疫调节活性的回顾性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4627295e4350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035274, encodeId=779920352e400, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Clin Trans Gastroenterology：抗丙二醛-乙醛加合物的免疫球蛋白G自身抗体可作为诊断溃疡性结肠炎的新型血清学生物标志物, objectType=article, longId=726267, objectId=4a39e26267cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a39e26267cc, replyNumber=0, likeNumber=105, createdTime=2022-10-06, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a39e26267cc, moduleTitle=Clin Trans Gastroenterology：抗丙二醛-乙醛加合物的免疫球蛋白G自身抗体可作为诊断溃疡性结肠炎的新型血清学生物标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4a39e26267cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035265, encodeId=b0c72035265fb, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局, objectType=article, longId=218722, objectId=0a93218e222e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a93218e222e, replyNumber=0, likeNumber=79, createdTime=2021-12-05, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a93218e222e, moduleTitle=Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0a93218e222e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035262, encodeId=7e60203526286, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=BJHaem：TEAD4通过直接与γ-球蛋白基因启动子结合来调节胎儿血红蛋白的抑制, objectType=article, longId=217897, objectId=fc3a21e897e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc3a21e897e9, replyNumber=0, likeNumber=89, createdTime=2021-12-21, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc3a21e897e9, moduleTitle=BJHaem：TEAD4通过直接与γ-球蛋白基因启动子结合来调节胎儿血红蛋白的抑制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fc3a21e897e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035264, encodeId=baee203526426, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=百济神州宣布，澳大利亚首次核准百悦泽®（泽布替尼）用于治疗华氏巨球蛋白血症患者, objectType=article, longId=218474, objectId=6abd2184e426, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6abd2184e426, replyNumber=0, likeNumber=100, createdTime=2021-12-01, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6abd2184e426, moduleTitle=百济神州宣布，澳大利亚首次核准百悦泽®（泽布替尼）用于治疗华氏巨球蛋白血症患者, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6abd2184e426)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035263, encodeId=8724203526332, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=J Clin Oncol：伊布替尼（Ibrutinib）+利妥昔单抗对比安慰剂+ 利妥昔单抗治疗Waldenstrm巨球蛋白血症的疗效:来自随机III期iNNOVATE研究最终分析结果, objectType=article, longId=218141, objectId=54be2181415e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54be2181415e, replyNumber=0, likeNumber=0, createdTime=2021-12-04, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54be2181415e, moduleTitle=J Clin Oncol：伊布替尼（Ibrutinib）+利妥昔单抗对比安慰剂+ 利妥昔单抗治疗Waldenstrm巨球蛋白血症的疗效:来自随机III期iNNOVATE研究最终分析结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=54be2181415e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035275, encodeId=f2b220352e56d, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=JAMA子刊：静脉注射免疫球蛋白IVIG维持治疗能明显减少MOGAD复发风险，成人也一样!, objectType=article, longId=726120, objectId=371fe2612089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=371fe2612089, replyNumber=0, likeNumber=117, createdTime=2022-09-10, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=371fe2612089, moduleTitle=JAMA子刊：静脉注射免疫球蛋白IVIG维持治疗能明显减少MOGAD复发风险，成人也一样!, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=371fe2612089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035257, encodeId=fbc1203525e0b, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=J Clin Oncol：伊沙佐米+皮下注射利妥昔单抗+地塞米松可有效治疗复发或难治性巨球蛋白血症！, objectType=article, longId=215762, objectId=968f215e627f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968f215e627f, replyNumber=0, likeNumber=73, createdTime=2022-07-30, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968f215e627f, moduleTitle=J Clin Oncol：伊沙佐米+皮下注射利妥昔单抗+地塞米松可有效治疗复发或难治性巨球蛋白血症！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=968f215e627f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035269, encodeId=776820352691c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=JEADV：DUPILUMA治疗伴有STAT3高免疫球蛋白E综合征的儿童湿疹, objectType=article, longId=293516, objectId=04f729351643, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04f729351643, replyNumber=0, likeNumber=107, createdTime=2022-10-06, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04f729351643, moduleTitle=JEADV：DUPILUMA治疗伴有STAT3高免疫球蛋白E综合征的儿童湿疹, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=04f729351643)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035258, encodeId=62752035258d5, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Clin Cancer Res：国产BTK抑制剂泽布替尼治疗难治/复发性Waldenström巨球蛋白血症的疗效和安全性, objectType=article, longId=216579, objectId=57b22165e959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b22165e959, replyNumber=0, likeNumber=86, createdTime=2022-07-29, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b22165e959, moduleTitle=Clin Cancer Res：国产BTK抑制剂泽布替尼治疗难治/复发性Waldenström巨球蛋白血症的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=57b22165e959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035253, encodeId=68802035253e6, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Laryngoscope：成人鼻窦炎患者的免疫球蛋白替代疗法治疗结果 , objectType=article, longId=213379, objectId=cc7c2133e953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc7c2133e953, replyNumber=0, likeNumber=94, createdTime=2022-02-05, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc7c2133e953, moduleTitle=Laryngoscope：成人鼻窦炎患者的免疫球蛋白替代疗法治疗结果 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cc7c2133e953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035272, encodeId=60ca20352e2da, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=实验性心脏肌球蛋白激活剂omecamtiv mecarbil在心衰患者中对运动能力没有任何益处, objectType=article, longId=299004, objectId=752f2990048e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=752f2990048e, replyNumber=0, likeNumber=86, createdTime=2022-09-27, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=752f2990048e, moduleTitle=实验性心脏肌球蛋白激活剂omecamtiv mecarbil在心衰患者中对运动能力没有任何益处, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=752f2990048e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035271, encodeId=40fa20352e1a7, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=CARDIOVASC DIABETOL：胎球蛋白A可以预测糖尿病血管并发症风险！, objectType=article, longId=294429, objectId=53bb29442939, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53bb29442939, replyNumber=0, likeNumber=92, createdTime=2022-08-30, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53bb29442939, moduleTitle=CARDIOVASC DIABETOL：胎球蛋白A可以预测糖尿病血管并发症风险！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=53bb29442939)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035270, encodeId=18da20352e01a, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Autoimmun Rev：静脉注射免疫球蛋白可有效改善系统性硬化症的皮肤受累情况, objectType=article, longId=293806, objectId=254d29380696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=254d29380696, replyNumber=0, likeNumber=76, createdTime=2022-12-02, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=254d29380696, moduleTitle=Autoimmun Rev：静脉注射免疫球蛋白可有效改善系统性硬化症的皮肤受累情况, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=254d29380696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035259, encodeId=5701203525903, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=内幕消息 - 美国FDA批准百济神州:百悦泽用于治疗华氏巨球蛋白血症患者, objectType=article, longId=216612, objectId=93a521661262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93a521661262, replyNumber=0, likeNumber=0, createdTime=2022-08-10, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93a521661262, moduleTitle=内幕消息 - 美国FDA批准百济神州:百悦泽用于治疗华氏巨球蛋白血症患者, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=93a521661262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035249, encodeId=d05220352495a, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后, objectType=article, longId=211025, objectId=13fb211025c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13fb211025c6, replyNumber=0, likeNumber=93, createdTime=2021-06-14, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13fb211025c6, moduleTitle=Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=13fb211025c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035267, encodeId=3b4e203526e5e, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, objectTitle=BJH：接受莫加珠单抗治疗的成人 T 细胞白血病-淋巴瘤患者外周血单核细胞中免疫球蛋白 G 重链库的临床意义, objectType=article, longId=264963, objectId=806926496392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=806926496392, replyNumber=0, likeNumber=77, createdTime=2022-09-10, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=806926496392, moduleTitle=BJH：接受莫加珠单抗治疗的成人 T 细胞白血病-淋巴瘤患者外周血单核细胞中免疫球蛋白 G 重链库的临床意义, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=806926496392)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

球蛋白

2020-05-29

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

X连锁无丙种球蛋白血症：症状与体征、病因、流行病学、诊断与治疗

2022-12-23

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病

2022-11-08

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

JAMA Netw open：川崎病患者对静脉注射免疫球蛋白无反应和冠状动脉异常的发生是否与年龄和性别有关?

2022-07-16

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Front Immunol：20%皮下免疫球蛋白治疗自身免疫性肌炎和CVID患者的替代和免疫调节活性的回顾性研究

2022-06-08

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Clin Trans Gastroenterology：抗丙二醛-乙醛加合物的免疫球蛋白G自身抗体可作为诊断溃疡性结肠炎的新型血清学生物标志物

2022-10-06

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局

2021-12-05

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

BJHaem：TEAD4通过直接与γ-球蛋白基因启动子结合来调节胎儿血红蛋白的抑制

2021-12-21

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

百济神州宣布，澳大利亚首次核准百悦泽®（泽布替尼）用于治疗华氏巨球蛋白血症患者

2021-12-01

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

J Clin Oncol：伊布替尼（Ibrutinib）+利妥昔单抗对比安慰剂+ 利妥昔单抗治疗Waldenstrm巨球蛋白血症的疗效:来自随机III期iNNOVATE研究最终分析结果

2021-12-04

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

JAMA子刊：静脉注射免疫球蛋白IVIG维持治疗能明显减少MOGAD复发风险，成人也一样!

2022-09-10

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

J Clin Oncol：伊沙佐米+皮下注射利妥昔单抗+地塞米松可有效治疗复发或难治性巨球蛋白血症！

2022-07-30

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

JEADV：DUPILUMA治疗伴有STAT3高免疫球蛋白E综合征的儿童湿疹

2022-10-06

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Clin Cancer Res：国产BTK抑制剂泽布替尼治疗难治/复发性Waldenström巨球蛋白血症的疗效和安全性

2022-07-29

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Laryngoscope：成人鼻窦炎患者的免疫球蛋白替代疗法治疗结果

2022-02-05

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

实验性心脏肌球蛋白激活剂omecamtiv mecarbil在心衰患者中对运动能力没有任何益处

2022-09-27

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

CARDIOVASC DIABETOL：胎球蛋白A可以预测糖尿病血管并发症风险！

2022-08-30

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Autoimmun Rev：静脉注射免疫球蛋白可有效改善系统性硬化症的皮肤受累情况

2022-12-02

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

内幕消息 - 美国FDA批准百济神州:百悦泽用于治疗华氏巨球蛋白血症患者

2022-08-10

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后

2021-06-14

xzw113 (审核中...)

前往app查看评论内容

#球蛋白#

BJH：接受莫加珠单抗治疗的成人 T 细胞白血病-淋巴瘤患者外周血单核细胞中免疫球蛋白 G 重链库的临床意义

2022-09-10

科室
- - 订阅+
  - 更多科室
工具
服务